NEWS
CSL Seqirus Canada News Releases
2024
CSL Seqirus Canada News Releases
2024
Accessibility Statement
CSL is committed to providing an accessible website experience for all customers and consumers, regardless of disability.
FLUAD® Adjuvanted Flu Vaccines for Quebec Seniors Aged 65 and Older: CSL Seqirus Welcomes the Comité sur l’Immunisation du Québec (CIQ)’s Recommendation
FLUAD® Influenza vaccine (surface antigen, inactivated, adjuvanted with MF59®) is now preferentially recommended by the Comité sur l’immunisation du Québec (Quebec Immunization Committee, or CIQ) for adults 65 years of age and older.
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Announces U.S. Government Award in Response to Avian Influenza
· CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government’s outbreak and preparedness response.
· Outbreaks of highly pathogenic avian influenza (HPAI) viruses in birds and livestock have been reported in the U.S.
· Fourth avian influenza pandemic preparedness award to CSL Seqirus under a multi-year agreement with Biomedical Advanced Research and Development Authority (BARDA).